Coronary Artery Disease and Preoperative Coronary Angiography in Elective Thoracic Endovascular Aortic Repair: A Retrospective Cohort Study
Related Experiment Video
Updated: Jun 26, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Marwan Hamiko1, Lamis Keswani2, Ali Bayram1
1Heart Center, Department of Cardiac Surgery, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
Insights
Routine preoperative coronary angiography (CAG) for thoracic endovascular aortic repair (TEVAR) candidates identifies significant coronary artery disease (CAD) without impacting short-term outcomes. While CAD patients have higher unadjusted mortality, this is explained by systemic atherosclerosis, suggesting routine assessment is justified.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Vascular Surgery
Background:
- Coronary artery disease (CAD) often coexists with thoracic aortic disease, potentially increasing risks after thoracic endovascular aortic repair (TEVAR).
- The benefit of routine preoperative coronary angiography (CAG) in patients undergoing elective TEVAR remains uncertain.
- Evaluating the impact of preoperative CAG on outcomes in TEVAR patients is crucial for optimizing perioperative care.
Purpose of the Study:
- To investigate whether routine preoperative coronary angiography (CAG) improves outcomes in patients undergoing elective thoracic endovascular aortic repair (TEVAR).
- To assess the prevalence and impact of coronary artery disease (CAD) in patients undergoing TEVAR.
- To determine the association between preoperative coronary revascularization and long-term survival in TEVAR patients with CAD.
Main Methods:
- Retrospective analysis of 177 patients undergoing elective TEVAR from 2015-2025 with a median follow-up of 4.9 years.
- Comparison of outcomes between patients who underwent preoperative CAG versus those who did not.
- Analysis of survival using Kaplan-Meier and overlap-weighted Cox regression, comparing patients with and without CAD.
Main Results:
- Preoperative CAG was performed in 53.1% of patients, identifying significant CAD in 44.7% of those assessed.
- No significant differences in in-hospital mortality or major adverse cardiovascular events were observed between patients who underwent CAG and those who did not.
- While CAD patients had higher unadjusted mortality, this association was attenuated after adjustment for comorbidities, and preoperative revascularization did not improve survival.
Conclusions:
- Preoperative CAG identifies clinically relevant CAD in a substantial proportion of TEVAR candidates, enabling timely revascularization.
- Outcomes were comparable between patients who underwent CAG and those who did not, irrespective of CAD burden.
- The long-term survival disadvantage associated with CAD appears largely attributable to systemic atherosclerosis, supporting the justification for routine preoperative coronary assessment in elective TEVAR.
Abstract:
(1) Background: Coronary artery disease (CAD) frequently coexists with thoracic aortic disease and may increase the risk of adverse outcomes after thoracic endovascular aortic repair (TEVAR). Whether routine preoperative coronary angiography (CAG) improves outcomes remains unclear. (2) Methods: We retrospectively analyzed 177 patients undergoing elective TEVAR between 2015 and 2025 with a median follow-up of 4.9 years. Two analyses were performed: patients who underwent preoperative CAG versus those who did not, and patients with versus without CAD. Survival was assessed using Kaplan-Meier analysis and overlap-weighted Cox regression. (3) Results: Preoperative CAG was performed in 94 patients (53.1%) and identified newly diagnosed or progressive CAD in 42 (44.7%). Overall, 24 patients (13.6%) underwent coronary revascularization before TEVAR. Patients with CAD were older and had a greater comorbidity burden. Despite these differences, preoperative CAG was not associated with differences in in-hospital mortality (2.1% vs. 6.0%, p = 0.159), major adverse cardiovascular events (11.3% vs. 9.0%, p = 0.754), or long-term survival (log-rank p = 0.10). Patients with CAD showed higher unadjusted long-term mortality than those without CAD (31.7% vs. 17.5%; log-rank p = 0.003). However, after overlap weighting, CAD was no longer significantly associated with mortality (adjusted HR 1.4, 95% CI 0.71-2.8). Among patients with angiographically verified coronary disease, preoperative revascularization before TEVAR was not associated with improved long-term survival (HR 2.20, 95% CI 0.69-6.98). (4) Conclusions: Preoperative CAG detects clinically relevant, often unrecognized CAD in a substantial proportion of TEVAR candidates and enables revascularization before surgery. Despite a higher coronary burden, patients who underwent CAG had outcomes comparable to those who did not, and the crude long-term survival disadvantage of CAD was largely explained by the accompanying systemic atherosclerotic burden. Routine preoperative coronary assessment appears justified in elective TEVAR.
Related Concept Videos
Aneurysm IV: Nursing Management
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease V: Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies